Antiamyloid Monoclonal Antibodies in Alzheimer’s Disease Part 2: Challenges in Dementia Care Delivery System Logistics

What is it about?

Anti-amyloid therapies are the first disease-targeting medications available to treat Alzheimer's disease. In the past, Alzheimer's treatments have focused on oral medications and providing support for patients and caregivers, therefore spanning multiple medical specialities and healthcare settings. However, the complex care required for anti-amyloid therapies has multiple logistical hurdles. In Part 2 of this two-part series, the complex care coordination for the safe delivery of anti-amyloid therapies is discussed.

Featured Image